Deutsche Bank’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-49,404
| Closed | -$3.35M | – | 5270 |
|
|
2019
Q3 | $3.35M | Sell |
49,404
-658,176
| -93% | -$45.2M | ﹤0.01% | 1608 |
|
|
2019
Q2 | $41.2M | Buy |
707,580
+318,507
| +82% | +$18.9M | 0.02% | 651 |
|
|
2019
Q1 | $27.3M | Buy |
389,073
+76,473
| +24% | +$5.67M | 0.02% | 832 |
|
|
2018
Q4 | $20.1M | Sell |
312,600
-9,331
| -3% | -$654K | 0.01% | 894 |
|
|
2018
Q3 | $22.6M | Buy |
321,931
+232,264
| +259% | +$13.6M | 0.01% | 1064 |
|
|
2018
Q2 | $4.52M | Buy |
89,667
+25,962
| +41% | +$1.03M | ﹤0.01% | 2376 |
|
|
2018
Q1 | $1.99M | Buy |
63,705
+15,182
| +31% | +$504K | ﹤0.01% | 2872 |
|
|
2017
Q4 | $1.66M | Buy |
48,523
+16,883
| +53% | +$538K | ﹤0.01% | 2857 |
|
|
2017
Q3 | $1.01M | Sell |
31,640
-16,355
| -34% | -$516K | ﹤0.01% | 3003 |
|
|
2017
Q2 | $1.56M | Buy |
47,995
+25,451
| +113% | +$806K | ﹤0.01% | 2716 |
|
|
2017
Q1 | $707K | Buy |
22,544
+5,980
| +36% | +$177K | ﹤0.01% | 2872 |
|
|
2016
Q4 | $486K | Sell |
16,564
-36,225
| -69% | -$1.1M | ﹤0.01% | 3188 |
|
|
2016
Q3 | $1.52M | Buy |
52,789
+34,901
| +195% | +$972K | ﹤0.01% | 2532 |
|
|
2016
Q2 | $461K | Sell |
17,888
-50,467
| -74% | -$1.34M | ﹤0.01% | 3330 |
|
|
2016
Q1 | $1.69M | Buy |
68,355
+51,024
| +294% | +$1.4M | ﹤0.01% | 2484 |
|
|
2015
Q4 | $608K | Buy |
17,331
+7,307
| +73% | +$196K | ﹤0.01% | 3180 |
|
|
2015
Q3 | $210K | Sell |
10,024
-64,797
| -87% | -$1.67M | ﹤0.01% | 3779 |
|
|
2015
Q2 | $2.08M | Buy |
74,821
+70,617
| +1,680% | +$1.99M | ﹤0.01% | 2429 |
|
|
2015
Q1 | $127K | Sell |
4,204
-10
| -0.2% | -$318 | ﹤0.01% | 4024 |
|
|
2014
Q4 | $133K | Sell |
4,214
-119
| -3% | -$3.87K | ﹤0.01% | 4535 |
|
|
2014
Q3 | $121K | Sell |
4,333
-42,845
| -91% | -$1.19M | ﹤0.01% | 4387 |
|
|
2014
Q2 | $1.29M | Sell |
47,178
-54,577
| -54% | -$1.45M | ﹤0.01% | 2765 |
|
|
2014
Q1 | $2.68M | Buy |
101,755
+70,297
| +223% | +$2.02M | ﹤0.01% | 2216 |
|
|
2013
Q4 | $919K | Sell |
31,458
-57,921
| -65% | -$1.84M | ﹤0.01% | 2711 |
|
|
2013
Q3 | $2.73M | Sell |
89,379
-12,208
| -12% | -$408K | ﹤0.01% | 2263 |
|
|
2013
Q2 | $3.22M | Buy |
+101,587
| New | +$3.34M | ﹤0.01% | 1899 |
|
Deutsche Bank's GHDX Position: Q4 2019 in Review
Deutsche Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 49,404 shares — an estimated $3.35M sold.
Deutsche Bank first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $41.2M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Deutsche Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Deutsche Bank sold 49,404 Genomic Health, Inc. shares in Q4 2019, an estimated $3.35M.
- Deutsche Bank first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Deutsche Bank's Genomic Health, Inc. position peaked at $41.2M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.